Targeting inflammation driven by HMGB1

H Yang, H Wang, U Andersson - Frontiers in immunology, 2020 - frontiersin.org
High mobility group box 1 (HMGB1) is a highly conserved, nuclear protein present in all cell
types. It is a multi-facet protein exerting functions both inside and outside of cells …

Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity

K Tsuchiya - International journal of molecular sciences, 2021 - mdpi.com
Pyroptosis is a necrotic form of regulated cell death. Gasdermines (GSDMs) are a family of
intracellular proteins that execute pyroptosis. While GSDMs are expressed as inactive forms …

Neutrophil extracellular traps (NETs) and damage‐associated molecular patterns (DAMPs): two potential targets for COVID‐19 treatment

S Cicco, G Cicco, V Racanelli… - Mediators of …, 2020 - Wiley Online Library
COVID‐19 is a pandemic disease caused by the new coronavirus SARS‐CoV‐2 that mostly
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …

Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury

H Fan, HB Tang, Z Chen, HQ Wang, L Zhang… - Journal of …, 2020 - Springer
Background Spinal cord injury (SCI) favors a persistent pro-inflammatory macrophages/
microglia-mediated response with only a transient appearance of anti-inflammatory …

Covid-19-induced dysautonomia: a menace of sympathetic storm

HM Al-Kuraishy, AI Al-Gareeb, S Qusti… - ASN …, 2021 - journals.sagepub.com
Among the plethora of debilitating neurological disorders of COVID-19 syndrome in
survivors, the scope of SARS-CoV-2-induced dysautonomia (DNS) is yet to be understood …

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

U Andersson, W Ottestad, KJ Tracey - Molecular Medicine, 2020 - Springer
Background The 2019 novel coronavirus disease (COVID-19) causes for unresolved
reasons acute respiratory distress syndrome in vulnerable individuals. There is a need to …

Targeting ACE2 for COVID-19 therapy: opportunities and challenges

H Jia, E Neptune, H Cui - American journal of respiratory cell and …, 2021 - atsjournals.org
The coronavirus disease (COVID-19) pandemic is sweeping the globe. Even with a number
of effective vaccines being approved and available to the public, new cases and escalating …

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

YN Paudel, E Angelopoulou, C Piperi… - European journal of …, 2019 - Elsevier
High mobility group box 1 (HMGB1) is a ubiquitous protein, released passively by necrotic
tissues or secreted actively by stressed cells. Extracellular HMGB1 is a typical damage …

HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia

S Zhang, L Hu, J Jiang, H Li, Q Wu, K Ooi… - Journal of …, 2020 - Springer
Background Microglial mediated neuroinflammation in the rostral ventrolateral medulla
(RVLM) plays roles in the etiology of stress-induced hypertension (SIH). It was reported that …

[HTML][HTML] The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways

D Prantner, S Nallar, SN Vogel - FASEB journal: official publication …, 2020 - ncbi.nlm.nih.gov
Although the innate immune receptor protein, Receptor for Advanced Glycation End
products (RAGE), has been extensively studied, there has been renewed interest in RAGE …